Krammer Anja B Insider Trades

Insider Trading History

Track insider trading activity for Krammer Anja B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vivos Therapeutics
Vivos Therapeutics VVOS
Director
Holding Value $4.89k 7,067 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.52k 4,000 shares
$2.38
$0.69
Vivos Therapeutics
Vivos Therapeutics VVOS
Director
Holding Value $53.1k 76,667 shares
Last Trade
Dec 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$358k 30,000 shares
$11.93
$0.69
Vivos Therapeutics
Vivos Therapeutics VVOS
Director
Holding Value $32.3k 46,667 shares
Last Trade
Aug 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.04M 30,000 shares
$67.88
$0.69
Vivos Therapeutics
Vivos Therapeutics VVOS
Director
Holding Value $0 0 shares
Last Trade
Dec 10, 2020 Sale
No data
No data
$0.69
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
Director
Holding Value $646k 1,884,126 shares
Last Trade
Jan 23, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$321k 115,874 shares
$2.77
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
Director
Holding Value $685k 2,000,000 shares
Last Trade
Oct 12, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38M 297,500 shares
$4.65
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
Director
Holding Value $787k 2,297,500 shares
Last Trade
Oct 11, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$463k 100,000 shares
$4.62
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
Director
Holding Value $821k 2,397,500 shares
Last Trade
Oct 10, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$474k 102,500 shares
$4.62
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $357k 1,042,000 shares
Last Trade
Sep 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.2M 1,042,000 shares
$4.03
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $671k 1,960,000 shares
Last Trade
Jan 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.54M 1,960,000 shares
$2.82
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $322k 940,000 shares
Last Trade
Dec 20, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.43M 940,000 shares
$2.58
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $363k 1,060,000 shares
Last Trade
Apr 18, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.5M 1,060,000 shares
$18.40
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $137k 400,000 shares
Last Trade
Dec 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.2M 400,000 shares
$10.50
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $159k 465,000 shares
Last Trade
Jul 21, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.6M 360,000 shares
$15.55
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
President
Holding Value $36k 105,000 shares
Last Trade
Jul 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.71M 105,000 shares
$16.25
$0.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up